[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.168.87. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
July 18, 2001

The Pharmaceutical Industry and Continuing Education—Reply

Author Affiliations
 

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor

JAMA. 2001;286(3):302-304. doi:10.1001/jama.286.3.302

In Reply: I admire Dr Dermksian's confidence in the "inherent intelligence" and "rigorous scientific and clinical training," which he believes allow practitioners to "make appropriate judgments of industry-supported CME." Would that it were true, but experienced medical educators know that most busy clinicians do not have the time or the training to evaluate the research literature for themselves and must depend on the opinions of unbiased experts. Neither CME speakers paid by the drug companies nor the sales representatives who work for the companies can be considered unbiased. If their presentations did not put the company's products in a favorable light, why would companies invest billions of dollars in activities that did not serve their commercial interests?

First Page Preview View Large
First page PDF preview
First page PDF preview
×